Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-13 · accession 0001628280-25-013147 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-17 | 2025-03-13 | MYGN | Fox Jennifer Lynne | CLO | A - Grant | $0.00 | +63.1K | 124.9K | +102% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-13 | A | A | 63,145 | $0.00 | 124,916 | D | — | — | (F1) Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. |